In a previous study, we identified a series of pyrimidine diamines that bind to the regulatory domains of Hck (27), a Src-family kinase expressed in myeloid hematopoietic cells and potential target for AML therapy (18, 20, 39). The gene discussed is HCK; the disease is acute myeloid leukemia.